R2R01
Sponsors
River 2 Renal Corp.
Conditions
Acute Kidney InjuryHeart FailureHepatorenal SyndromeWorsening Heart Failure (WHF)
Phase 2
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
NCT05875948
Start: 2023-06-30End: 2024-12-31Target: 95Updated: 2023-10-03
To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)
CompletedNCT06264310
Start: 2024-03-01End: 2024-11-25Updated: 2026-06-22
Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury
RecruitingNCT07625553
Start: 2026-04-07End: 2027-04-30Target: 430Updated: 2026-06-04